During treatment with remdesivir and dexamethasone, viruses with the T21I mutation in the 3CL protease showed a decreasing trend during disease progression while increasing during improvement.
← all excerpts
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019.
1
—
—